Patient Advocacy Voices
Patient advocacy is a critical area in healthcare that is transforming the lives of patients across the country by helping them overcome barriers to access and care. Join Sanofi US Head of Public Affairs and Patient Advocacy, Eric Racine, and his co-hosts to meet some of the unsung heroes leading patient advocacy organizations. In each episode, we will discuss the challenges each group has faced and share actionable insights to address gaps and help make the U.S. healthcare system work better for patients. Whether you're a seasoned advocate or new to the field, we hope this podcast will open your mind to new ideas and inspire action. Subscribe now and become part of a community dedicated to making a difference for patients.
This podcast is provided as a resource only and does not constitute an endorsement by Sanofi of any particular organization or its programming. Additional resources on this topic may be available and should be investigated.
Patient Advocacy Voices
How to Create Partnerships That Build Trust and Deliver Outcomes
Building trust and improving health in underserved communities can be a daunting challenge. Most would agree that “it takes a village,” but how do you create that village, and who are the right partners? In this premier episode of “Patient Advocacy Voices,” Sanofi host Eric Racine and his co-host Courtney Peters discuss this challenge with Dr. Laura Lee Hall, a patient advocacy leader and President Emeritus of the National Minority Quality Forum (NMQF) Center for Sustainable Health Care Quality and Equity. Dr. Hall saw disparities in influenza immunization rates in communities of color and decided to do something about it. In this episode, Eric and Courtney discuss with Dr. Hall how she connected clinical care providers in local healthcare systems with community organizations and national partners to improve outcomes and equitable care through the DRIVE initiative, Demonstrating Real Improvement in Value and Equity. Because of its success, the DRIVE program keeps expanding and now extends to other health conditions and inequities. The results are impressive, and Dr. Hall’s insights have universal applicability for advocacy programs across therapeutic areas.